Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 473,851 $ 546,636
Restricted cash 179,014
Prepaid income taxes 25,633 25,633
Prepaid expenses 42,665 51,790
Total current assets 721,163 624,059
Marketable securities held in Trust Account 10,303,227 11,877,654
Total Assets 11,024,390 12,501,713
Current liabilities:    
Accounts payable and accrued expenses 358,268 268,423
March promissory note - related party 87,301 366,346
Due to related party 795,003 795,003
Advances due - 180 667,315 1,699,825
Convertible promissory notes, net of debt discount 1,838,118  
Derivative liability 256,670
Total current liabilities 4,002,675 3,129,597
Deferred underwriting fees 4,025,000
Total Liabilities 4,002,675 7,154,597
Commitments
Common stock subject to possible redemption, $0.0001 par value; 190,970 and 33,618 shares as of September 30, 2020 and December 31, 2019, respectively (at approximately $10.59 and $10.33 per share, respectively) 2,021,705 347,106
Stockholders' Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized (see Note 10); no shares issued and outstanding as of September 30, 2020 and December 31, 2019
Common stock, $0.0001 par value; 35,000,000 shares authorized (see Note 10); 5,276,946 and 4,458,149 shares issued and outstanding (excluding 190,970 and 33,618 shares subject to possible redemption, respectively) as of September 30, 2020 and December 31, 2019, respectively 528 446
Additional paid-in capital 8,342,826 3,929,663
(Accumulated deficit)/Retained earnings (3,343,344) 1,069,901
Total Stockholders' Equity 5,000,010 5,000,010
Total Liabilities and Stockholders' Equity $ 11,024,390 $ 12,501,713